(Q67726432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730120%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730120%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience (English)

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

10 November 2022

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

10 November 2022

author name string

D. B. Glasser

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730120

10 November 2022

J. M. Lane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730120

10 November 2022

A. G. Huvos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730120

10 November 2022

R. C. Marcove

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730120

10 November 2022

G. Rosen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1730120

10 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730120%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

10 November 2022

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

10 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730120%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730120%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730120%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

698-708

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730120%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

cites work

Clinical orthopaedics

2

48

209

Goidanich

1966

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

The unreliability of prognostic criteria in osteosarcoma

10 November 2022

3

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Osteosarcoma:A Multifactorial Clinical and Histopathological Study with Special Regard to Therapy and Survival

10 November 2022

5

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

10 November 2022

Cancer Treatment Reports

7

62

189

Dahlin

1978

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Can historical controls be used in current clinical trials in osteosarcoma? Analysis of prognostic factors

10 November 2022

8

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

10 November 2022

Clinical orthopaedics

9

167

250

Brostrom

1982

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

The prognosis in osteosarcoma: Norwegian National Data

10 November 2022

10

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

The treatment of osteosarcoma of the extremities: twenty year's experience at the Istituto Ortopedico Rizzoli

10 November 2022

11

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Trends and variability in survival among patients with osteosarcoma: a 7-year update

10 November 2022

12

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival

10 November 2022

13

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group

10 November 2022

14

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group

10 November 2022

15

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Prognostic factors in osteosarcomas. A regression analysis

10 November 2022

16

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Prognostic variables in osteosarcoma: a multi-institutional study

10 November 2022

17

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery

10 November 2022

19

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

10 November 2022

20

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy

10 November 2022

21

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Primary Osteogenic Sarcoma of the Femur: A Model for the Use of Preoperative Chemotherapy in High Risk Malignant Tumors

10 November 2022

22

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

10 November 2022

Clinical orthopaedics

26

204

93

Lane

1986

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Nonparametric Estimation from Incomplete Observations

10 November 2022

27

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

10 November 2022

28

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Analysis of survival by tumor response.

10 November 2022

30

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Local recurrence after amputation for osteosarcoma

10 November 2022

31

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

En bloc resections for osteogenic sarcoma

10 November 2022

34

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Comparing survival of responders and nonresponders after treatment: a potential source of confusion in interpreting cancer clinical trials.

10 November 2022

35

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

Effect of cumulative courses of intraarterial cis-diamminedichloroplatin-II on the primary tumor in osteosarcoma

10 November 2022

36

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

10 November 2022

39

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

10 November 2022

40

7

138

Bacci

1988

1 reference

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

https://api.crossref.org/works/10.1002/1097-0142(19920201)69:3%3C698::AID-CNCR2820690317%3E3.0.CO;2-G

10 November 2022

Identifiers

10.1002/1097-0142(19920201)69:3<698::AID-CNCR2820690317>3.0.CO;2-G

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1730120%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference